Here are seven highlights:
1. In the fourth quarter, Implanet reported $2.33 million in revenue. The knee business took a 27 percent dive in the quarter, due to the planned ending of arthroscopy implant distribution.
2. The JAZZ business reached $1.47 million in revenue in the fourth quarter, with the number of sold units increasing 16 percent to 2,821.
3. The company saw 2017 revenue of $9.58 million.
4. The 2017 full-year JAZZ sales increased 30 percent to 9,117 units, hitting $5.77 million, a 15 percent increase over 2016. The JAZZ business captures 60 percent of the company’s total revenue.
5. Implanet sold 1,537 JAZZ units in the U.S., reflecting a 6 percent boost and $2.46 million in revenue for 2017.
6. In 2017, Implanet sold 4,101 JAZZ units in France, totaling $1.84 million in revenue.
7. The company sold 3,479 JAZZ units in the rest of the world in 2017, reflecting a 58 percent boost from the year prior.
More articles on devices:
J&J’s 2017 full-year orthopedics sales fall flat, spine business line sales drop: 5 things to know
Europe spinal implants market to hit $3.8B by 2024 — 4 observations
19 spine, orthopedic device companies to impact the industry in 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
